Home/Filings/4/0001104659-25-003461
4//SEC Filing

Cassidy James 4

Accession 0001104659-25-003461

CIK 0001773427other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:31 PM ET

Size

7.5 KB

Accession

0001104659-25-003461

Insider Transaction Report

Form 4
Period: 2025-01-10
Cassidy James
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2025-01-10+17,32381,731 total
  • Award

    Stock Option (Right to Buy)

    2025-01-10+50,61550,615 total
    Exercise: $43.00Exp: 2035-01-10Common Stock (50,615 underlying)
Footnotes (2)
  • [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 10, 2026, another thirty-three percent (33%) to vest on January 10, 2027 and the remaining thirty-four percent (34%) to vest on January 10, 2028, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
  • [F2]This option shall vest in forty-eight (48) equal monthly installments following January 10, 2025, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.

Issuer

SpringWorks Therapeutics, Inc.

CIK 0001773427

Entity typeother

Related Parties

1
  • filerCIK 0001949023

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:31 PM ET
Size
7.5 KB